[ad_1] U.S. biotech stocks have been on the up recently. The S & P Biotechnology Select Industry Index is up more than 6% in the past week. The Nasdaq Biotechnology Index , meanwhile, is up almost 4% over the same period and 8.5% over the past month. “Biotech looks to …
Read More »UBS calls Ralph Lauren a ‘turnaround stock,’ sees fashion brand rallying 36%
[ad_1] Changes in Ralph Lauren ‘s business make the clothing brand a good investment coming out of the pandemic, according to UBS. Analyst Jay Sole reiterated his buy rating and increased his price target to $130 from $128, which implies an upside of 36.2% over Thursday’s close. “We view RL …
Read More »Deutsche Bank names Walmart a top pick, sees more outperformance from the retail giant
[ad_1] Even as other retail companies struggle, Walmart is poised to outperform as more consumers look for value, according to Deutsche Bank. Analyst Krisztina Katai named the big-box retailer a top pick, calling the stock a defensive winner that will build on its recent gains. Walmart shares are up nearly …
Read More »Club names that have been big winners before
[ad_1] Strange, but true: The S & P 500 has been solidly higher 12 months after the midterm elections in every cycle since 1954, according to Yardeni Research, regardless of which party won or lost. The broad market index’s average one-year gain in 17 post-elections windows has been about 15%. …
Read More »We still see Estee Lauder shares as a buy on weakness despite downbeat guidance
[ad_1] Estee Lauder (EL) reported a better-than-expected fiscal first quarter, but a downbeat forecast for the rest of its fiscal year sent shares lower Wednesday. However, if not for our Club trading restrictions , we would have been buyers on the weakness. First, the headline numbers: Quarterly revenue declined 11% …
Read More »We’re impressed with health insurer Humana’s solid quarter and rosy outlook for next year
[ad_1] Club holding Humana (HUM) reported a mixed-but-solid third quarter before the opening bell Wednesday. Early optimism about 2023 also supported our bullish view on the health insurer’s stock. Revenue increased 9% year-over-year to $22.75 billion, slightly below estimates of $22.76 billion, and adjusted earnings-per-share increased 42% to $6.88, exceeding …
Read More »Eli Lilly CEO on guidance cut, potential obesity drug, Alzheimer’s study
[ad_1] Eli Lilly (LLY) CEO David Ricks on Tuesday expressed optimism around the drugmaker’s innovation pipeline Tuesday, a stance we share despite the Club holding’s cluttered quarterly report issued earlier in the day . “The underlying fundamentals of the business are really strong,” Ricks said in a CNBC interview with …
Read More »We’re exiting a drug stock for a nice gain and putting some of that money to work elsewhere
[ad_1] Traders work on the floor of the New York Stock Exchange (NYSE) on October 27, 2022 in New York City. Stocks continued their upward gains Thursday with the Dow rising nearly 400 points following a new GDP report that beat expectations. Spencer Platt | Getty Images [ad_2] Source link
Read More »McDonald’s (MCD) earnings Q3 2022
[ad_1] McDonald’s restaurant sign is seen in Streator, Illinois, United States, on October 15, 2022. Beata Zawrzel | Nurphoto | Getty Images McDonald’s is due to report its third-quarter earnings before the bell on Thursday. Here’s what Wall Street analysts surveyed by Refinitiv are expecting: Earnings per share: $2.58 Revenue: …
Read More »Deutsche Bank upgrades Humana for the same reasons we own this big 2022 winner
[ad_1] Deutsche Bank analysts took Humana to a buy rating from a hold, citing its “leading position in Medicare Advantage.” [ad_2] Source link
Read More »